Maintenance of biologic-free remission with naproxen or no treatment in patients with early, active axial spondyloarthritis: results from a 6-month, randomised, open-label follow-up study, INFAST Part 2-Reference-Cited by-同舟云学术

Maintenance of biologic-free remission with naproxen or no treatment in patients with early, active axial spondyloarthritis: results from a 6-month, randomised, open-label follow-up study, INFAST Part 2

Published:2013-06-05 Issue:1 Volume:73 Page:108-113
ISSN:0003-4967
Container-title:Annals of the Rheumatic Diseases
language:en
Short-container-title:Ann Rheum Dis

Author:

Sieper J,Lenaerts J,Wollenhaupt J,Rudwaleit M,Mazurov V I,Myasoutova L,Park S,Song Y,Yao R,Chitkara D,Vastesaeger N,

Publisher

BMJ

Subject

General Biochemistry, Genetics and Molecular Biology,Immunology,Immunology and Allergy,Rheumatology

Reference16 articles.

1. 2010 Update of the international ASAS recommendations for the use of anti-TNF agents in patients with axial spondyloarthritis;van der Heijde;Ann Rheum Dis,2011

2. Recombinant human tumor necrosis factor receptor (etanercept) for treating ankylosing spondylitis: a randomized, controlled trial;Davis;Arthritis Rheum,2003

3. Efficacy and safety of infliximab in patients with ankylosing spondylitis: results of a randomized, placebo-controlled trial (ASSERT);van der Heijde;Arthritis Rheum,2005

4. Efficacy of adalimumab in the treatment of axial spondyloarthritis without radiographically defined sacroiliitis: results of a twelve-week randomized, double-blind, placebo-controlled trial followed by an open-label extension up to week fifty-two;Haibel;Arthritis Rheum,2008

5. Clinical and imaging efficacy of infliximab in HLA-B27-positive patients with magnetic resonance imaging-determined early sacroiliitis;Barkham;Arthritis Rheum,2009

Cited by 48 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. ASAS consensus definition of early axial spondyloarthritis;Annals of the Rheumatic Diseases;2023-06-15

2. Décroissance ou arrêt des traitements de fond biologiques dans la spondyloarthrite axiale : revue de la littérature;Revue du Rhumatisme;2023-05

3. Suppression of acute bone marrow edema (osteitis) in the sacroiliac joints with long-term use of non-steroidal anti-inflammatory drugs in patients with axial spondyloarthritis;Modern Rheumatology Journal;2023-04-22

4. Correspondence on "ASAS-EULAR recommendations for the management of axial spondyloarthritis: 2022 update" by Ramiroet al;Annals of the Rheumatic Diseases;2023-02-03

5. Tapering or discontinuation of biological disease-modifying antirheumatic drugs in axial spondyloarthritis: A review of the literature and discussion on current practice;Joint Bone Spine;2023-01